Chemours Co Stock Performance
| CC Stock | USD 12.61 0.04 0.32% |
The firm shows a Beta (market volatility) of 3.87, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Chemours will likely underperform. At this point, Chemours has a negative expected return of -0.21%. Please make sure to confirm Chemours' jensen alpha, maximum drawdown, and the relationship between the coefficient of variation and sortino ratio , to decide if Chemours performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Chemours Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in December 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return (0.78) | Five Day Return 11.16 | Year To Date Return (24.30) | Ten Year Return 116.24 | All Time Return (39.33) |
Forward Dividend Yield 0.0277 | Payout Ratio | Forward Dividend Rate 0.35 | Dividend Date 2025-12-15 | Ex Dividend Date 2025-11-14 |
1 | Disposition of 1294 shares by Familiar Calderon Gerardo of Chemours at 15.4 subject to Rule 16b-3 | 08/29/2025 |
| Chemours dividend paid on 12th of September 2025 | 09/12/2025 |
2 | Agri-Science Giant Corteva Eyes Breakup To Shield Seed Unit From Future Risks Report | 09/15/2025 |
3 | Jim Cramer on Chemours I Think its Chronically Undervalued | 09/25/2025 |
4 | Chemours Is Down 14.9 percent After Legal and Environmental Risks IntensifyHas the Bull Case Changed | 10/14/2025 |
5 | Earnings Preview Chemours Q3 Earnings Expected to Decline | 10/30/2025 |
6 | Innospec Tops Q3 Earnings and Revenue Estimates | 11/04/2025 |
7 | Chemours CFO Discusses Growth, Innovation, and Culture On Inside the ICE House Podcast | 11/05/2025 |
8 | Chemours Non-GAAP EPS of 0.20 misses by 0.04, revenue of 1.5B in-line | 11/06/2025 |
9 | Trump administration moves to loosen restrictions it once supported on a harmful pollutant | 11/07/2025 |
10 | Chemours price target lowered by 2 at RBC Capital, heres why CC | 11/10/2025 |
| Begin Period Cash Flow | 1.8 B | |
| Total Cashflows From Investing Activities | -353 M |
Chemours Relative Risk vs. Return Landscape
If you would invest 1,498 in Chemours Co on August 14, 2025 and sell it today you would lose (237.00) from holding Chemours Co or give up 15.82% of portfolio value over 90 days. Chemours Co is generating negative expected returns and assumes 3.3718% volatility on return distribution over the 90 days horizon. Put differently, 30% of stocks are less risky than Chemours on the basis of their historical return distribution, and some 99% of all equities are expected to be superior in generating returns on investments over the next 90 days. Expected Return |
| Risk |
Chemours Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chemours' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Chemours Co, and traders can use it to determine the average amount a Chemours' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.063
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CC |
Estimated Market Risk
| 3.37 actual daily | 30 70% of assets are more volatile |
Expected Return
| -0.21 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Chemours is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chemours by adding Chemours to a well-diversified portfolio.
Chemours Fundamentals Growth
Chemours Stock prices reflect investors' perceptions of the future prospects and financial health of Chemours, and Chemours fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Chemours Stock performance.
| Return On Equity | -0.67 | ||||
| Return On Asset | 0.0283 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 5.71 B | ||||
| Shares Outstanding | 149.89 M | ||||
| Price To Earning | 25.49 X | ||||
| Price To Book | 6.41 X | ||||
| Price To Sales | 0.32 X | ||||
| Revenue | 5.78 B | ||||
| Gross Profit | 1.02 B | ||||
| EBITDA | 692 M | ||||
| Net Income | 86 M | ||||
| Cash And Equivalents | 713 M | ||||
| Cash Per Share | 7.73 X | ||||
| Total Debt | 4.36 B | ||||
| Debt To Equity | 2.94 % | ||||
| Current Ratio | 1.82 X | ||||
| Book Value Per Share | 1.99 X | ||||
| Cash Flow From Operations | (633 M) | ||||
| Earnings Per Share | (2.13) X | ||||
| Market Capitalization | 1.9 B | ||||
| Total Asset | 7.51 B | ||||
| Retained Earnings | 1.72 B | ||||
| Working Capital | 1.22 B | ||||
| Current Asset | 2.3 B | ||||
| Current Liabilities | 1.47 B | ||||
About Chemours Performance
By analyzing Chemours' fundamental ratios, stakeholders can gain valuable insights into Chemours' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Chemours has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Chemours has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 116.02 | 67.76 | |
| Return On Tangible Assets | 0.01 | 0.01 | |
| Return On Capital Employed | 0.08 | 0.13 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.14 | 0.18 |
Things to note about Chemours performance evaluation
Checking the ongoing alerts about Chemours for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Chemours help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Chemours generated a negative expected return over the last 90 days | |
| Chemours has high historical volatility and very poor performance | |
| Chemours Co reports about 713 M in cash with (633 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.73. | |
| Over 100.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thefly.com: Chemours price target lowered by 2 at RBC Capital, heres why CC |
- Analyzing Chemours' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Chemours' stock is overvalued or undervalued compared to its peers.
- Examining Chemours' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Chemours' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Chemours' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Chemours' stock. These opinions can provide insight into Chemours' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |